Delivery Order SPE2DB20D1004-SPE2DB25FNCHX

Award Date 10/29/24
Potential Completion Date 10/30/24
Potential Value $3.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,944.14 delivery order contract is for the supply of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product, with a period of performance through March 3, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award, valued at $7,938.27, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order type, with a Firm Fixed Price pricing structure, and an ultimate completion date of November 25, 2024. The contract covers the procurement of JARDIANCE 25 MG TABLET 90S, a medical product used for diabetes management. This award is part of a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $32,726.93 firm fixed-price delivery order contract is for the supply of JARDIANCE 25 MG TABLET 90S, a medical product. The contract has an ultimate completion date of January 3, 2025. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order with a firm fixed price of $16,517.06 and a completion date of November 18, 2024. The contract is with AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide JARDIANCE 25 MG TABLET 90S, a medication used for diabetes management. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,131.71, is for the delivery of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product. It is a firm fixed-price delivery order contract with an ultimate completion date of November 1, 2023. The contract is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $31,178.95 firm fixed-price delivery order is for the supply of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of July 8, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $43,806.51, is for the delivery of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product. The contract type is a Delivery Order with a Firm Fixed Price pricing arrangement. The contract has an Ultimate Completion Date of March 4, 2025. This award is part of a larger Indefinite Delivery Contract...
This federal contract award is a delivery order with a firm fixed-price valued at $12,813.72, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of JARDIANCE 25 MG TABLET 90S, a medication used to treat diabetes. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,776.01, is for the delivery of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of November 30, 2023. This award is part of a larger Indefinite Delivery Contract...
This federal contract award, valued at $4,677.39, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product, with an ultimate completion date of July 18, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB25FNCHX
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order valued at $3,754.96 and has an ultimate completion date of October 30, 2024. The contract is for the supply of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product used for the treatment of diabetes.

The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/20/25, 2:09 PM